Taro Pharmaceutical Industries Ltd.(TAROF.PK: News ) reported first quarter net income of $11.10 million or $0.27 per ordinary share, compared to $7.54 million or $0.19 per ordinary share in the same quarter of last year.
Net sales for the quarter were $84.90 million, compared to $78.06 million in the prior year quarter.
Gross profit for the first quarter was about $47 million, or 55% of net sales, compared to $41 million, or 52% of net sales, for same quarter in 2008.
No comments:
Post a Comment